First-in-class Claudin 18.2 targeting radiopeptide, 64Cu-PD-29875 and 177Lu-PD-29875, exhibit promising theranostic potential in a pancreatic cancer xenograft …
用户sToGMn7iJdc8
19天前
32
10
已关闭
DOI:
文献链接:
其他信息:
S Tsuchida, Y Mizukoshi, S Kato, H Inaba…
Cancer …, 2025
aacrjournals.org
… PD-29875 is selectively binding to hCLDN18.2. In in vivo biodistribution experiment, 64 Cu-PD-29875 and 177 Lu-PD-29875 … lower, suggesting PD-29875 distinguishes physiological …

